drugset
drugset / Trial / NCT03414879

Ketamine Versus Lidocaine Nebulization for Awake Fiberoptic Intubation

NCT03414879 ↗

Phase 4 Completed 60 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized double-blinded study is performed to compare ketamine versus lidocaine for nebulization for awake nasal fiberoptic intubation as regard efficacy and side effects.

Timeline

Start
2018-01-15
Primary completion
2019-07-25
Completion
2019-07-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 3 mg/kg Other
Comparator Lidocaine Other / unclassified 4 % Other

Indications

No indication recorded.